Pharmaceutical
March 26, 2013
The Psychopharmacologic Drugs Advisory Committee (PDAC) of the U.S. Food and Drug Administration (FDA) has recommended the approval of a new treatment for opioid addiction by Titan Pharmaceuticals, called Probuphine.
Read More
March 20, 2013
The U.S. Food and Drug Administration (FDA) is investigating a possible link between a number of commonly used diabetes drugs and pre-cancerous changes to the pancreas.
Read More
March 7, 2013
German chemical and pharmaceutical giant Bayer has developed an ambitious program that aims to cement the company's position among the leading names in the global pharmaceutical industry.
Read More
February 28, 2013
The U.S. Food and Drug Administration (FDA) has given the green light to two generic versions of Suboxone, a drug used for treating heroin addiction, manufactured by Reckitt Benckiser.
Read More
February 27, 2013
Recent research by a team of scientists at Birmingham University in central England has dismissed fears that British patients might have to cope with a shortage of drugs.
Read More
February 25, 2013
New Jersey-based pharmaceutical giant Merck & Co. has agreed to pay $8.5 million to the state of Pennsylvania to settle allegations that it inappropriately marketed its painkiller Vioxx.
Read More
February 20, 2013
A 20-year-old engineer suffered chemical burns Tuesday in an industrial accident at a GlaxoSmithKline (GSK) plant.
Read More
February 12, 2013
Asia is emerging as a strategically important location for global pharmaceutical companies that are looking to take advantage of the opportunities available in terms of R&D, manufacturing and market.
Read More
Globalization impacts demand and production of pharmaceuticals
February 5, 2013
Pharmaceutical manufacturers today face a considerable checklist of significant challenges, including the fight against counterfeiting, reducing costs through offshore manufacturing and maintaining product integrity.
Read More
February 4, 2013
Following the approval of 39 new drugs in 2012, and with a number of new pharmaceutical products already in their final stages of development, global pharma companies are optimistic about the next 12 months.
Read More